ESTA Stock Overview
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Establishment Labs Holdings Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$24.46 |
52 Week High | US$79.88 |
52 Week Low | US$16.96 |
Beta | 1.04 |
1 Month Change | -30.73% |
3 Month Change | -57.43% |
1 Year Change | -63.86% |
3 Year Change | -20.46% |
5 Year Change | -1.65% |
Change since IPO | -1.17% |
Recent News & Updates
Recent updates
Is Establishment Labs Holdings (NASDAQ:ESTA) Using Too Much Debt?
Aug 10Shareholders Should Be Pleased With Establishment Labs Holdings Inc.'s (NASDAQ:ESTA) Price
Apr 17Establishment Labs Holdings (NASDAQ:ESTA) Is Carrying A Fair Bit Of Debt
Dec 14Establishment Labs drops 18% after new short report from Hindenburg Research
Oct 19Establishment Labs: Flat Earnings, Return On Investment Keep Buyers At Bay
Sep 24Establishment Labs Holdings (NASDAQ:ESTA) Is Carrying A Fair Bit Of Debt
Sep 04Establishment Labs started at buy at B Riley on breast implants
Aug 24Health Check: How Prudently Does Establishment Labs Holdings (NASDAQ:ESTA) Use Debt?
Feb 23Is Establishment Labs Holdings (NASDAQ:ESTA) Using Debt Sensibly?
Sep 25Is Establishment Labs Holdings (NASDAQ:ESTA) Weighed On By Its Debt Load?
Jun 09Is Establishment Labs Holdings (NASDAQ:ESTA) Using Debt Sensibly?
Feb 24Did Establishment Labs Holdings' (NASDAQ:ESTA) Share Price Deserve to Gain 92%?
Jan 20Establishment Labs reports Q4, FY20 prelim revenue guidance
Jan 11What You Need To Know About Establishment Labs Holdings Inc.'s (NASDAQ:ESTA) Investor Composition
Dec 16Shareholder Returns
ESTA | US Medical Equipment | US Market | |
---|---|---|---|
7D | -1.6% | 1.2% | 0.6% |
1Y | -63.9% | 0.1% | 14.6% |
Return vs Industry: ESTA underperformed the US Medical Equipment industry which returned 0% over the past year.
Return vs Market: ESTA underperformed the US Market which returned 13.6% over the past year.
Price Volatility
ESTA volatility | |
---|---|
ESTA Average Weekly Movement | 13.3% |
Medical Equipment Industry Average Movement | 8.2% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 15.6% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: ESTA is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week.
Volatility Over Time: ESTA's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 958 | Juan Chacon Quiros | https://www.establishmentlabs.com |
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.
Establishment Labs Holdings Inc. Fundamentals Summary
ESTA fundamental statistics | |
---|---|
Market Cap | US$654.50m |
Earnings (TTM) | -US$71.52m |
Revenue (TTM) | US$177.40m |
3.6x
P/S Ratio-8.8x
P/E RatioIs ESTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ESTA income statement (TTM) | |
---|---|
Revenue | US$177.40m |
Cost of Revenue | US$62.85m |
Gross Profit | US$114.56m |
Other Expenses | US$186.08m |
Earnings | -US$71.52m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -2.77 |
Gross Margin | 64.57% |
Net Profit Margin | -40.32% |
Debt/Equity Ratio | 607.9% |
How did ESTA perform over the long term?
See historical performance and comparison